Novo Nordisk Rebranding Diabetes Tablet as Ozempic
Idag, 14:30
08:30 AM EDT, 05/01/2026 (MT Newswires) -- Novo Nordisk (NVO) said Friday it has rebranded its oral semaglutide medication for type 2 diabetes, formerly known as Rybelsus, as Ozempic.
Starting May 4, Ozempic 1.5 mg, 4 mg and 9 mg tablets will be available for adults with type 2 diabetes in the US, the company said.
Rybelsus was first approved by the FDA in 2019 and offered 3 mg, 7 mg and 14 mg tablets, the company said.
"The new Ozempic pill works similarly to semaglutide tablets 3 mg, 7 mg, and 14 mg and has the same efficacy and safety profile as the original formulation offered in a smaller pill,"Novo Nordisk said.
Ämnen i artikeln
Novo Nordisk Rebranding Diabetes Tablet as Ozempic
Idag, 14:30
08:30 AM EDT, 05/01/2026 (MT Newswires) -- Novo Nordisk (NVO) said Friday it has rebranded its oral semaglutide medication for type 2 diabetes, formerly known as Rybelsus, as Ozempic.
Starting May 4, Ozempic 1.5 mg, 4 mg and 9 mg tablets will be available for adults with type 2 diabetes in the US, the company said.
Rybelsus was first approved by the FDA in 2019 and offered 3 mg, 7 mg and 14 mg tablets, the company said.
"The new Ozempic pill works similarly to semaglutide tablets 3 mg, 7 mg, and 14 mg and has the same efficacy and safety profile as the original formulation offered in a smaller pill,"Novo Nordisk said.
Ämnen i artikeln
Analys
Rapporter
